Join our daily newsletter At The Bell to receive exclusive market insights
Pro Medicus Ltd (ASX:PME) has signed a seven-year contract worth A$40 million with U.S. radiology service provider LucidHealth which will see the latter implement the cloud-based Visage 7 enterprise imaging platform throughout its system.
The contract – based on a transactional licensing model – was signed between LucidHealth and Pro Medicus’ wholly owned U.S. subsidiary Visage Imaging Inc; the Visage platform roll out is to commence immediately through its cloud-based implementation, followed by a phased ‘go live’ as early as 2025’s third quarter.
CEO Dr Sam Hupert said LucidHealth, which employs more than 300 radiologists across 140 care sites, would be an important addition to Pro Medicus’ client list.
“Their needs, which include subspecialized onsite and remote reading/teleradiology capabilities, are uniquely catered for by our proprietary server-side streaming
technology reinforcing our view that Visage 7 is ideally positioned to address this market and the other key market segments we service, which include academic medical centers, IDNs and outpatient clinics,” he said.
Pro Medicus has been trading at $253.25 through Monday.
Join the discussion: See what HotCopper users are saying about Pro Medicus and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
